Solventum Corp reported 1.95B in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Abbott USD 9.07B 369M Jun/2025
Align Technology USD 849.42M 1.25M Jun/2025
Baxter International USD 2.54B 29M Jun/2025
Becton, Dickinson and Co. USD 4.53B 196M Jun/2025
Cencora USD 79.68B 1.14B Jun/2025
Dexcom USD 944.5M 42.2M Jun/2025
Insulet USD 528M 8.3M Jun/2025
Solventum Corp 1.95B 29M Jun/2025
West Pharmaceutical Services USD 612.8M 21.8M Jun/2025
Zimmer Biomet Holdings USD 1.68B 110.7M Jun/2025